Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer
2019en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references